资讯
Klotho Neurosciences, Inc. (NASDAQ: KLTO) today announced that it is moving forward with manufacturing and process ...
Corcept's main revenue driver, Korlym, helps treat hyperglycemia in adults with Cushing's Syndrome. Read why I rate CORT ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果